Box score
Gilgamesh Pharma Inc.
Reported $60M sold in a new Form D filed March 24, 2026 (New York, New York).
- Biggest raise
- $60M filed Mar 24, 2026
- League
- Bio & Health Pharmaceuticals
- Based in
- New York, New York
- Season rank
- #34 of 1,121 in the Bio & Health League; #392 of 10,745 overall (2026)
- Incorporated
- 2025
- Entity
- Corporation
Form D filings since 2024 4
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-03-31 | New notice | $2.2M | $15M | SEC |
| 2026-03-24 | New notice | $60M | $60M | SEC |
| 2026-02-04 | New notice | $6.1M | $6.1M | SEC |
| 2026-02-04 | New notice not ranked | $0 | $4.4M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2107396.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | VantAI Holdings, Inc. rookie | Bio & Health | $86.3M |
| 2 | Click Therapeutics, Inc. | Bio & Health | $50M |
| 3 | Amani Therapeutics, Inc. | Bio & Health | $35M |
| 4 | Covera Health, Inc. | Bio & Health | $31.7M |
| 5 | Atommap Corp | Bio & Health | $31.1M |
| 6 | XWELL, Inc. | Bio & Health | $31M |